Thu 13 Aug 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Study Title | Study Sponsor | Status | Study Drug | Trial Phase | Study Protocol Number | Site |
|---|---|---|---|---|---|---|
| Effect of celecoxib on postoperative narcotic use and disease severity in patients with aspirin-exacerbated respiratory disease and chronic rhinosinusitis: a randomized controlled trial | King Khalid University Hospital | Ongoing | Celecoxib | 4 | 114809 | King Khalid University Hospital (Riyadh), King Abdulaziz University Hospital (Riyadh) |
| EASi-HF - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral BI 690517 and empagliflozin compared with placebo and empagliflozin in participants with symptomatic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) >40% | Boehringer Ingelheim | Ongoing | BI 690517 , empagliflozin | 3 | 1378-0020 | King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh),King Abdulaziz Medical City NG (Riyadh), King Abdulaziz University Hospital (Jeddah) |
| Effect of Probiotics “Psychobiotics” on Depression in Adults with Obesity and Metabolic Syndrome in Riyadh City | King Khalid University Hospital | Ongoing | Winclove’s Ecologic® Barrier probiotics | 3 | E-23-7867 | King Khalid University Hospital (Riyadh) |
| BalanceD-HF: A Phase III, Randomised, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared with Dapagliflozin, on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function | AstraZeneca | Ongoing | balcinrenone/dapagliflozin | 3 | D6402C00012 | King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical NG (City Riyadh),King Abdulaziz Medical City NG (Jeddah),King Fahad Medical City (Riyadh) ,King Khalid University Hospital (Riyadh) |
| A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) | Janssen Research & Development | Rejected | Nipocalimab | 3 | 80202135EBF3001 | King Faisal Specialist Hospital and Research Center (Riyadh), King Saud Medical City (Riyadh), King Fahad University Hospital (Al-Khobar) |
| REAL-WORLD, LONG-TERM DATA COLLECTION TO GAIN CLINICAL INSIGHTS INTO ROCHE OPHTHALMOLOGY PRODUCTS (VOYAGER STUDY)- COMPLETE | Roche | Ongoing | Vabysmo | 4 | MR41927 | King Abdulaziz Medical City NG (Jeddah) |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN) | Biogen Idec Research Limited | Ongoing | Litifilimab | 3 | 230LE305 | King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Multicenter, Open-label, Single-arm, Phase 3 Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of BIIB059 (Litifilimab) in Adult Participants with Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus with or without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST LTE) | Biogen Idec Research Limited | Ongoing | Litifilimab | 3 | 230LE305 | King Faisal Specialist Hospital and Research Center ,(Riyadh) King Khalid University Hospital (Riyadh) |
| A multicenter real-world evidence study with retrospective chart review and cross-sectional survey to evaluate the satisfaction and benefits of long-term repeated BOTOX treatment for upper facial lines | 4 | |||||
| Phase II, Prospective, Randomized, placebo-controlled, double-blind study.Evaluation of Phytochemical properties and Phytotherapeutic Potential of Boswellia carteri Birdw. in Psoriasis | 2 |
Last update date: 08/05/2025 at 03:17 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.